Literature DB >> 29895072

Fully vs. partially covered selfexpandable metal stent for palliation of malignant esophageal strictures: a randomized trial (the COPAC study).

Paul Didden1, Agnes N Reijm1, Nicole S Erler2, Leonieke M M Wolters3, Thjon J Tang4, Pieter C J Ter Borg5, Ivonne Leeuwenburgh6, Marco J Bruno1, Manon C W Spaander1.   

Abstract

BACKGROUND: Covered esophageal self-expandable metal stents (SEMSs) are currently used for palliation of malignant dysphagia. The optimal extent of the covering to prevent recurrent obstruction is unknown. Therefore, we aimed to compare fully covered (FC) versus partially covered (PC) SEMSs in patients with incurable malignant esophageal stenosis.
METHODS: In this multicenter randomized controlled trial, 98 incurable patients with dysphagia caused by a malignant stricture of the esophagus or cardia were randomized 1:1 to an FC-SEMS or PC-SEMS. The primary outcome was recurrent obstruction after endoscopic SEMS placement. Secondary outcomes were technical and clinical success, adverse events, and health-related quality of life (HRQoL). Patients were followed until 6 months after SEMS placement or to SEMS removal, second SEMS insertion, or death, whichever came first.
RESULTS: Recurrent obstruction after SEMS placement was similar for both types of stents: 19 % for FC-SEMSs and 22 % for PC-SEMSs (P = 0.65). The times to recurrent obstruction did not differ. The frequency of adverse events was similar between the two groups, with major adverse events occurring in 38 % and 47 % of patients for FC-SEMSs and PC-SEMSs, respectively (P = 0.34). No significant differences were seen in technical success, improvement of dysphagia, and HRQoL. Proximal esophageal stenosis and female sex were independently associated with recurrent obstruction and/or major adverse events.
CONCLUSIONS: Esophageal FC-SEMSs did not reveal a lower recurrent obstruction rate compared with PC-SEMSs in the palliative management of malignant dysphagia. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2018        PMID: 29895072     DOI: 10.1055/a-0620-8135

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  8 in total

Review 1.  Recent Updates in Gastrointestinal Stent Placement from the Esophagus to the Colon: A Radiological Perspective.

Authors:  Gun Ha Kim; Ji Hoon Shin; Chu Hui Zeng; Jung Hoon Park
Journal:  Cardiovasc Intervent Radiol       Date:  2022-02-15       Impact factor: 2.740

Review 2.  Endoscopic Management of Luminal Strictures: Beyond Dilation.

Authors:  Nader D Daoud; Hassan Ghoz; Obaie Mzaik; Himesh B Zaver; Micah McKinney; Bhaumik Brahmbhatt; Timothy Woodward
Journal:  Dig Dis Sci       Date:  2022-02-25       Impact factor: 3.199

3.  Fully covered self-expandable esophageal metallic stents in patients with inoperable malignant disease who survived for more than 6 months after stent placement.

Authors:  Nader Bakheet; Jung-Hoon Park; Hong-Tao Hu; Sung Hwan Yoon; Kun Yung Kim; Wang Zhe; Jae Yong Jeon; Ho-Young Song
Journal:  Br J Radiol       Date:  2019-07-02       Impact factor: 3.039

4.  Validation of the efficacy of the NUTRISCORE for the nutritional screening of cancer patients in China.

Authors:  Junren Kang; Hailong Li; Xiaodong Shi; Enling Ma; Wei Chen
Journal:  BMC Cancer       Date:  2022-01-06       Impact factor: 4.430

5.  Balloon dilatation complications during esophagogastric anastomotic stricture treatment under fluoroscopy: Risk factors, prevention, and management.

Authors:  Shuai Wang; Xiaobing Li; Chenchen Zhang; Meipan Yin; Yaozhen Ma; Yalin Tong; Meng Wang; Chao Liu; Ming Zhu; Gang Wu
Journal:  Thorac Cancer       Date:  2022-04-28       Impact factor: 3.223

Review 6.  Endoscopic Management of Esophageal Cancer.

Authors:  Christopher Paiji; Alireza Sedarat
Journal:  Cancers (Basel)       Date:  2022-07-22       Impact factor: 6.575

7.  Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update.

Authors:  Andrew M Veitch; Franco Radaelli; Raza Alikhan; Jean-Marc Dumonceau; Diane Eaton; Jo Jerrome; Will Lester; David Nylander; Mo Thoufeeq; Geoffroy Vanbiervliet; James R Wilkinson; Jeanin E van Hooft
Journal:  Endoscopy       Date:  2021-08-06       Impact factor: 10.093

8.  Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update.

Authors:  Andrew M Veitch; Franco Radaelli; Raza Alikhan; Jean Marc Dumonceau; Diane Eaton; Jo Jerrome; Will Lester; David Nylander; Mo Thoufeeq; Geoffroy Vanbiervliet; James R Wilkinson; Jeanin E Van Hooft
Journal:  Gut       Date:  2021-09       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.